Table 1 Baseline patient characteristics according to nutritional status as evaluated by SGA

Number of patients

21 (7.3%)

63 (21.9%)

204 (70.8%)

Female

9 (42.9%)

37 (58.7%)

92 (45.1%)

0.148

Age (years)

53.4 ± 11.1

52.7 ± 12.6

46.4 ± 11.7

<0.001

Height (cm)

164.0 ± 7.9

163.4 ± 7.9

167.6 ± 9.8

0.002

Weight (kg)

59.1 ± 8.7

62.3 ± 9.7

67.0 ± 12.3

0.001

BMI (kg/m²)

22.0 ± 2.7

23.3 ± 2.6

23.7 ± 2.9

0.044

Hemoglobin (g/dL)

12.8 ± 1.1

13.2 ± 1.4

13.7 ± 1.5

<0.001

eGFR (mL/min/1.73 m²)

51.3 ± 23.2

57.1 ± 24.9

69.2 ± 24.6

<0.001

Protein (g/dL)

7.4 ± 0.4

7.2 ± 0.4

7.3 ± 0.4

0.328

Albumin (g/dL)

4.4 ± 0.3

4.3 ± 0.3

4.4 ± 0.4

0.377

Total cholesterol (mg/dL)

180.3 ± 30.2

175.8 ± 27.7

177.4 ± 26.0

0.654

Presence of hypertension

21 (100%)

55 (87.3%)

162 (79.4%)

0.011

Presence of liver cysts

17 (81%)

55 (87.3%)

155 (76.0%)

0.160

TKLV (mL)

4,581 [2,698–7,899]

3,445 [2,642–4,415]

2,808 [2,241–3,695]

<0.001

TKV (mL)

2,089 [817–2,801]

1,443 [913–2,070]

1,059 [638–1,628]

<0.001

TLV (mL)

2,039 [1,336–4,728]

1,659 [1,352–2,200]

1,636 [1,337–1,951]

0.120

htTKLV (mL/m)

2,622 [1,719–4,906]

2,147 [1,535–2,687]

1,649 [1,311–2,151]

<0.001

htTKV (mL/m)

1,282 [524–1,574]

903 [559–1,246]

640 [394–955]

<0.001

htTLV (mL/m)

1,298 [830–2,831]

1,023 [816–1,322]

957 [819–1,147]

0.036